These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 26666648

  • 1. In vitro characterization of transport and metabolism of the alkaloids: vincamine, vinpocetine and eburnamonine.
    Fandy TE, Abdallah I, Khayat M, Colby DA, Hassan HE.
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):259-67. PubMed ID: 26666648
    [Abstract] [Full Text] [Related]

  • 2. Cerebral metabolic and hemodynamic activities of l-eburnamonine in the anesthetized dog. A comparison with vincamine.
    Lacroix P, Quiniou MJ, Linee P, Le Polles JB.
    Arzneimittelforschung; 1979 Feb; 29(8):1094-101. PubMed ID: 40580
    [Abstract] [Full Text] [Related]

  • 3. Cerebral metabolic, hemodynamic and antihypoxic properties of l-eburnamonine.
    Linée P, Lacroix P, Le Polles JB, Aurousseau M, Boulu R, Van den Driessche J, Albert O.
    Eur Neurol; 1978 Feb; 17 Suppl 1():113-20. PubMed ID: 753626
    [Abstract] [Full Text] [Related]

  • 4. Metabolism of vincamine in the rat in vivo and in vitro.
    Vereczkey L, Tamás J, Czira G, Szporny L.
    Arzneimittelforschung; 1980 Feb; 30(11):1860-5. PubMed ID: 7192994
    [Abstract] [Full Text] [Related]

  • 5. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
    Barzaghi F, Dragonetti M, Formento ML, Gueniau C, Nencioni A, Mantegazza P.
    Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205
    [Abstract] [Full Text] [Related]

  • 6. [Agents to improve cerebrovascular circulation and cerebral metabolism--brovincamine].
    Maeda T.
    Nihon Rinsho; 1985 Feb; 43(2):389-91. PubMed ID: 3889412
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and metabolism of vincamine and related compounds.
    Vereczkey L.
    Eur J Drug Metab Pharmacokinet; 1985 Feb; 10(2):89-103. PubMed ID: 3899662
    [Abstract] [Full Text] [Related]

  • 8. [Study of the antihypoxic effect of eburnamonine in acute and recurrent anoxia on the cerebral electric activity in curarized rats. Comparison with vincamine].
    Van Den Driessche J, Linée P, Lacroix P, Le Pollès JB.
    C R Seances Soc Biol Fil; 1977 Feb; 171(5):1081-7. PubMed ID: 146550
    [Abstract] [Full Text] [Related]

  • 9. [Modifications by 1-eburnamonine and vincamine on 2,3-diphosphoglycerate blood levels in the presence or absence of histotoxic hypoxia produced by potassium cyanide in the awake rat].
    Lacroix P, Linée P, Le Pollès JB.
    C R Seances Soc Biol Fil; 1978 Feb; 172(2):330-6. PubMed ID: 150923
    [Abstract] [Full Text] [Related]

  • 10. Eburnamine derivatives and the brain.
    Vas A, Gulyás B.
    Med Res Rev; 2005 Nov; 25(6):737-57. PubMed ID: 16158388
    [Abstract] [Full Text] [Related]

  • 11. Severe hypocapnia applied to study the effect of vincamine on cerebral circulation.
    Palacios L, Roca J, Balasch J.
    Arch Farmacol Toxicol; 1978 Aug; 4(2):261-4. PubMed ID: 727839
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of L-eburnamonine on bronchial respiratory resistance in the anesthetized guinea pig. Comparison with vincamine].
    Linée P, Lacroix P, Laville MP, Le Pollès JB.
    C R Seances Soc Biol Fil; 1978 Aug; 172(6):1208-13. PubMed ID: 159107
    [Abstract] [Full Text] [Related]

  • 13. Positive allosteric action of eburnamonine on cardiac muscarinic acetylcholine receptors.
    Proska J, Tucek S.
    Eur J Pharmacol; 1996 Jun 03; 305(1-3):201-5. PubMed ID: 8813554
    [Abstract] [Full Text] [Related]

  • 14. The effect of an acute infusion of vincamine and ethyl apovincaminate on cerebral blood flow in healthy volunteers.
    Lim CC, Cook PJ, James IM.
    Br J Clin Pharmacol; 1980 Jan 03; 9(1):100-1. PubMed ID: 7356869
    [No Abstract] [Full Text] [Related]

  • 15. Cerebral antioedematous effect of Teproside and of some vincamine derivatives.
    Borzeix MG, Cahn J.
    Int J Clin Pharmacol Res; 1984 Jan 03; 4(4):259-61. PubMed ID: 6500773
    [Abstract] [Full Text] [Related]

  • 16. [Cardiovascular action of vincamine hydrochloride].
    Piacenza G, Pesce E, Marchini F.
    Farmaco Prat; 1978 Jul 03; 33(7):306-18. PubMed ID: 744231
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and pharmacological evaluation of (nitrooxy)alkyl apovincaminates.
    Kawashima Y, Ikemoto T, Horiguchi A, Hayashi M, Matsumoto K, Kawarasaki K, Yamazaki R, Okuyama S, Hatayama K.
    J Med Chem; 1993 Apr 02; 36(7):815-9. PubMed ID: 8464035
    [Abstract] [Full Text] [Related]

  • 18. Synthesis of vinca alkaloids and related compounds. Part 84. Sulfonamide derivatives of some vinca alkaloids with cardiovascular activity.
    Moldvai I, Temesvári-Major E, Szántay C, Tóth G, Kárpáti E, Szántay C.
    Arch Pharm (Weinheim); 1997 Jun 02; 330(6):190-8. PubMed ID: 9264244
    [Abstract] [Full Text] [Related]

  • 19. Neuroprotective effects of vinpocetine and its major metabolite cis-apovincaminic acid on NMDA-induced neurotoxicity in a rat entorhinal cortex lesion model.
    Nyakas C, Felszeghy K, Szabó R, Keijser JN, Luiten PG, Szombathelyi Z, Tihanyi K.
    CNS Neurosci Ther; 2009 Jun 02; 15(2):89-99. PubMed ID: 19492990
    [Abstract] [Full Text] [Related]

  • 20. [Metabolism of vincamine in the rat].
    Viganò V, Paracchini S, Piacenza G, Pesce E.
    Farmaco Sci; 1978 Aug 02; 33(8):583-94. PubMed ID: 744256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.